Financial News
All News about Tryp Therapeutics Inc
![](https://cdn2.benzinga.com/files/imagecache/og_image_social_share_1200x630/images/story/2012/psyched_cover_ver_2.jpg?width=720)
![](https://cdn2.benzinga.com/files/imagecache/og_image_social_share_1200x630/images/story/2021/analyst_ratings_image_101.jpeg?width=720)
![](https://cdn2.benzinga.com/files/imagecache/og_image_social_share_1200x630/images/story/2012/psyched_cover-01_39.jpg?width=720)
Psychedelics Gain More Traction as New Research Aims to Address Chronic Pain and Mental Illness
July 21, 2021
Topics
Law Enforcement
Exposures
Legal
![](https://cdn2.benzinga.com/files/imagecache/og_image_social_share_1200x630/images/story/2012/psyched_cover-01_38.jpg?width=720)
Tryp Therapeutics Partners with the University of Michigan to Evaluate Proprietary Formulations
July 07, 2021
Via Newsfile
Topics
Intellectual Property
Exposures
Intellectual Property
Tryp Therapeutics Reports on Key Milestones for 2021
April 20, 2021
Via Newsfile
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.